press release archive

Current \| 2007 \| 2006 \| 2005 \| 2004 \| 2003 \| 2002 \| 2001 \| 2000 \| 1999 \| 1998 \| 1997
8/5/2008		Rigel Announces Second Quarter 2008 Financial Results

5/6/2008		Rigel Announces First Quarter 2008 Financial Results

4/29/2008		Rigel’s R788 Slows Progression of Murine Lupus in Preclinical Studies

4/8/2008		Rigel’s R788 Shows Preclinical Activity in Type 1 Diabetes Model

2/26/2008		Daniel Magilavy, M.D. Joins Rigel as Vice President of Clinical Research

2/12/2008		Rigel Announces Fourth Quarter and Year End 2007 Financial Results

1/9/2008		Rigel Announces Initiation of Phase 1 Clinical Trial of R348 for Rheumatoid Arthritis, Psoriasis and Other Immune Disorders


© 2013 Rigel \| privacy \| disclaimer \| Follow Us On:	contact us \| site map \| search